These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8758858)

  • 1. [Influenced factors of nuclease P1-enhanced 32 P-postlabeling method].
    Chang P; Li G
    Zhonghua Yu Fang Yi Xue Za Zhi; 1996 Mar; 30(2):111-3. PubMed ID: 8758858
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of N-(deoxyguanosin-8-yl)-4-azobiphenyl by (32)P-postlabeling analyses of DNA in human uroepithelial cells exposed to proximate metabolites of the environmental carcinogen 4-aminobiphenyl.
    Hatcher JF; Swaminathan S
    Environ Mol Mutagen; 2002; 39(4):314-22. PubMed ID: 12112383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of an interlaboratory trial of 32P-postlabelling.
    Phillips DH; Castegnaro M
    IARC Sci Publ; 1993; (124):35-49. PubMed ID: 8225506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 32-P-HPLC analysis of DNA adducts formed in vitro and in vivo by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxaline, utilizing an improved adduct enrichment procedure.
    Wohlin P; Zeisig M; Gustafsson JA; Möller L
    Chem Res Toxicol; 1996 Sep; 9(6):1050-6. PubMed ID: 8870995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 32P-Postlabeling analysis of DNA adducts of styrene 7,8-oxide at the O6-position of guanine.
    Otteneder M; Eder E; Lutz WK
    Chem Res Toxicol; 1999 Jan; 12(1):93-9. PubMed ID: 9894023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization, and 32P-postlabeling of N-(deoxyguanosin)-4-aminobiphenyl 3'-phosphate adducts.
    Haack T; Boche G; Kliem C; Wiessler M; Albert D; Schmeiser HH
    Chem Res Toxicol; 2004 Jun; 17(6):776-84. PubMed ID: 15206898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a (32)P-postlabeling method for the detection of 1,N(2)-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal in vivo.
    Wacker M; Schuler D; Wanek P; Eder E
    Chem Res Toxicol; 2000 Nov; 13(11):1165-73. PubMed ID: 11087439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of DNA adducts by 32P-postlabeling and multifraction contact-transfer thin-layer chromatography.
    Laws GM; Adams SP; Nichols WW; Selden JR
    Fundam Appl Toxicol; 1994 Aug; 23(2):308-12. PubMed ID: 7982538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of genotoxicity of the metabolites of the pesticides Guthion, Sencor, Lorox, Reglone, Daconil and Admire by 32P-postlabeling.
    Shah RG; Lagueux J; Kapur S; Levallois P; Ayotte P; Tremblay M; Zee J; Poirier GG
    Mol Cell Biochem; 1997 Apr; 169(1-2):177-84. PubMed ID: 9089646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (32)P-postlabeling detection of DNA adducts in peripheral white blood cells of greenhouse floriculturists from western Liguria, Italy.
    Peluso M; Merlo F; Munnia A; Bolognesi C; Puntoni R; Parodi S
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):361-9. PubMed ID: 9162302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 32P-postlabeling detection of thymine glycols: evaluation of adduct recoveries after enhancement with affinity chromatography, nuclease P1, nuclease S1, and polynucleotide kinase.
    Reddy MV; Bleicher WT; Blackburn GR
    Cancer Commun; 1991 Apr; 3(4):109-17. PubMed ID: 2025496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in detection of DNA adducts in the 32P-postlabelling assay after either 1-butanol extraction or nuclease P1 treatment.
    Gallagher JE; Jackson MA; George MH; Lewtas J; Robertson IG
    Cancer Lett; 1989 Apr; 45(1):7-12. PubMed ID: 2540901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 32P-postlabeling of DNA adducts arising from complex mixtures: HPLC versus TLC separation applied to adducts from petroleum products.
    Eriksson HL; Zeisig M; Ekström LG; Möller L
    Arch Toxicol; 2004 Mar; 78(3):174-81. PubMed ID: 14652713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 32P-postlabeling assay for DNA adducts.
    Phillips DH; Arlt VM
    Nat Protoc; 2007; 2(11):2772-81. PubMed ID: 18007613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influences of DNA isolation and RNA contamination on carcinogen-DNA adduct analysis by 32P-postlabeling.
    Godschalk RW; Maas LM; Kleinjans JC; Van Schooten FJ
    Environ Mol Mutagen; 1998; 32(4):344-50. PubMed ID: 9882009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a 32P-postlabeling method for the detection of 1, N2-propanodeoxyguanosine adducts of 2-hexenal in vivo.
    Schuler D; Budiawan B; Eder E
    Chem Res Toxicol; 1999 Apr; 12(4):335-40. PubMed ID: 10207122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applicability of induced sputum for molecular dosimetry of exposure to inhalatory carcinogens: 32P-postlabeling of lipophilic DNA adducts in smokers and nonsmokers.
    Besaratinia A; Maas LM; Van Breda SG; Curfs DM; Kleinjans JC; Wouters EF; Van Schooten FJ
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):367-72. PubMed ID: 10794480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of cigarette-smoke-induced DNA adducts by butanol extraction and nuclease P1-enhanced 32P-postlabeling in human lymphocytes and granulocytes.
    Savela K; Hemminki K
    Environ Health Perspect; 1993 Oct; 101 Suppl 3(Suppl 3):145-50. PubMed ID: 8143607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postlabeling detection of DNA adducts of antitumor alkylating agents.
    Zhou GH; Teicher BA; Frei E
    Cancer Chemother Pharmacol; 1996; 38(1):71-80. PubMed ID: 8603455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods for testing compounds for DNA adduct formation.
    Reddy MV
    Regul Toxicol Pharmacol; 2000 Dec; 32(3):256-63. PubMed ID: 11162719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.